A Randomized Controlled Trial to Determine if Sitagliptin Will Enhance Islet Graft Function When Given for 1 Year Following Transplantation.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 23 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Jun 2010 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.
- 23 Jun 2010 Planned end date 1 Jul 2011 added as reported by ClinicalTrials.gov.